Effect of resistance-associated substitutions on retreatment of direct acting antiviral-exposed patients in the real-world setting (ANRS CO22 HEPATHER) - Université de Montpellier
Article Dans Une Revue Journal of Hepatology Année : 2017

Effect of resistance-associated substitutions on retreatment of direct acting antiviral-exposed patients in the real-world setting (ANRS CO22 HEPATHER)

Résumé

Re-treatment of patients with decompensated chronic hepatitis C virus cirrhosis using 24 weeks of sofosbuvir and NS5A inhibitor, with or without ribavirin after failing a 12 week course

Domaines

Sciences du Vivant [q-bio]

Marion Boutin  : Connectez-vous pour contacter le contributeur

https://hal.umontpellier.fr/hal-03155282

Soumis le : vendredi 5 mars 2021-13:59:05

Dernière modification le : mercredi 30 octobre 2024-18:08:04

Fichier non déposé

Dates et versions

hal-03155282 , version 1 (05-03-2021)

Identifiants

Citer

S. Chevaliez, P. Trimoulet, C. Dorival, S. Larrat, C. Scholtes, et al.. Effect of resistance-associated substitutions on retreatment of direct acting antiviral-exposed patients in the real-world setting (ANRS CO22 HEPATHER). Journal of Hepatology, 2017, 66 (1), pp.S84. ⟨10.1016/S0168-8278(17)30433-6⟩. ⟨hal-03155282⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

IPLESP BS UNIV-MONTPELLIER SORBONNE-UNIVERSITE SU-MEDECINE PCCI FMMS
35 Consultations
4 Téléchargements

Altmetric

Partager

More